Associação entre horas de sono, fatores demográficos antropométricos e dietéticos de crianças e adolescentes de uma escola do Sul do Brasil
Abstract
Association among sleep hours, demographic, anthropometric and dietary factors of children and adolescents from a school in the South of Brazil
Downloads
References
ABADIO, A. K.; KIOSHIMA, E.; TEIXEIRA, M.; MARTINS, N.; MAIGRET, B. FELIPE, M. S. Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics, 12(1):75, 2011.
BELLOZE KT; Priorização de alvos para fármacos no combate a doenças tropicais negligenciadas por protozoários. Instituto Oswaldo Cruz, Rio de Janeiro, 27 de set, 2013.
BAKHEET, T. M.; DOIG A. J; Properties and identification of human protein drug targets. Bioinformatics. 2009 Feb 15;25(4):451-7. Epub.Jan 21, 2009.
BERRIMAN, M.; et. al.The genome of the blood fluke schistosoma mansoni. Nature, 460 (7253):352–358, 2009.
CHEN, W. H., MINGUEZ, P., et al. "OGEE: an online gene essentiality database." Nucleic Acids Res 40(Database issue): D901-906. 2012.
FAUMAN, E. B.; RAI, B. K.; HUANG, E. S. Structure-based druggability assessment — identifying suitable targets for small molecule therapeutics. Chemical biology ; June, 2011.
FAN W.; CONG M.; CHEEMENG T.; Network motifs modulate druggability of cellular targets Sci Rep. ; 6: 36626. Published online Nov 8, 2016.
FLICEK P., AHMED I., et al. "Ensembl 2013." Nucleic Acids Res 41(Database issue): D48-55, 2013.
FILHO, O. A. S.; ALENCASTRO, R. B. Modelagem de proteínas por homologia. Quím. Nova vol.26 no.2 São Paulo Mar./ Apr. 2003.
GASHAW I; ELLINGHAUS P; SOMMER A; and ASADULLAH K. What makes a good drug target? Drug Discovery Today _ Volume 16, Numbers 23/24 _ December 2011.
GEYER, J. A.; PRIGGE, S. T. WARERS, N. C. Targeting malaria with specific cdk inhibitors. Biochimica et Biophysica Acta - Proteins and Proteomics, 1754(1,2):160– 170, 2005.
GRUBER, T.; Ontology by in the Encyclopedia of Database Systems, Ling Liu and M. Tamer Özsu (Eds.), Springer-Verlag, 2009.
GAULTON, A.; et al, ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. Jan; 40(Database issue): D1100–D1107, 2012.
HARLAND L, GAULTON A. A Expert Opin Drug Discov. Drug target central.
Aug;4(8):857-72, 2009.
HUGHES JP, REES S, KALINDJIAN SB, PHILPOTT KL; Br J Pharmacol. Principles of early drug Discovery; 162(6): 1239–1249, Mar 2011.
HUTHMACHER, C.; HOPPE, A.; BULIK, S.; HOLZHUTTER, H.G. Antimalarial drug targets in plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Systems Biology, 4(1):120, 2010.
JANGA, S. C.; TZAKOS, A. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Em Molecuar BioSystems. RSCPublishing, 2009.
METZGER I. F.; DEBORA C.; COSTA, S.; SANTOS, J. E. T.; Farmacogenética: princípios, aplicações e perspectivas; Medicina, Ribeirão Preto, simpósio: Farmacogenética39 (4): 515-21, out./dez. 2006
KATHRYN, A. L.; LIN, A.; CHENG A. C.; Structure-Based Druggability Assessment of the Mammalian Structural Proteome with Inclusion of Light Protein Flexibility. Computational Biology. Vol. 10. 1 July, 2014.
KELLER TH; PICHOTA A, YIN Z. A practical view of ‘druggability’ Current Opinion in Chemical Biology, 10:357–361, 2006.
KOONIN, E. V.; Orthologs, paralogs, and evolutionary genomics. Annu Rev Genet.;39:309-38, 2005.
KNOX, C., LAW, V., et al. (2011). "DrugBank 3.0: a comprehensive resource for 'omics' research on drugs." Nucleic Acids Res 39(Database issue): D1035-1041.
LIU, T., LIN, Y., et al. "BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities." Nucleic Acids Res 35(Database issue): D198-201. 2007.
NIH- National Institutes of Health. Turning Discovery Into Health®, 9000 Rockville Pike, Bethesda, Maryland 20892. Acesso em 2017.
OLIVA, G.; Bioinformática: Perspectivas na Medicina Bioinformática: Perspectivas na Medicina. Gazeta Médica da Bahia, (Suplemento 1):52-58, 2008.
RAMAN B., ITO I., STOPFER M. Bilateral olfaction: two is better than one for navigation. Genome Biol. 9(3): 212.,2008.
RODRIGUES, R. P.; MANTOANI, S. P.; ALMEIDA, J. R.; PINSETTA, F. R.;
SEMIGHINI, E. P.; SILVA, V. B.; SILVA, C. H. P. Estratégias de Triagem Virtual no Planejamento de Fármacos Rev. Virtual Quim., 4 (6), 739-776. 24 de dezembro, 2012.
SANTOS, E. C.; Mineração de dados usando álgebra linear para predição de alvos drogáveis. Tese. Universidade Federal de Minas Gerais. BH, 2012.
SILVEIRA, N. J. F; Bioinformática Estrutural Aplicada ao Estudo de Proteínas Alvo do Genoma do Mycobacterium tuberculosis. Tese de Doutorado. Universidade Estadual Paulista “Julio de Mesquita Filho” – UNESP; SP, 2005.
SCHMIDTKE, P.; BARRIL X.; Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J Med Chem. 12;53(15):5858-67. Aug, 2010.
U.S. National Library of Medicine. Clinical Trials. This page last reviewed in January 2017.
WYATT, P. G.; GILBERT. I. H.; READ, K. D.; FAIRLAMB, A. H. Target Validation: Linking Target and Chemical Properties to Desired Product Profile. Curr Top Med Chem.; 11(10): 1275–1283, May 2011.
ZHAO, S.; LI, S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE, 5(7):e11764, 2010.
ZHU, F. SHI, Z., et al. "Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery." Nucleic Acids Res 40(Database issue): D1128-1136, 2012.
Downloads
Published
Issue
Section
License
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.